GlassScriptPhysician profile
Gary R Hopen
NPI 1285741298
$1,238.42
in general payments reported to CMS, 2019-2025
18 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.51 · 2020: $186 · 2021: $280 · 2022: $175 · 2023: $96.77 · 2024: $81.92 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $24.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.38 |
| Education | $24.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $303.67 | 2021-2025 | Acthar |
| Alcon Vision LLC | $209.53 | 2020-2025 | Argos, Clareon |
| Abbvie INC. | $111.59 | 2023-2025 | |
| Amgen INC. | $74.27 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $72.43 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $68.79 | 2022-2025 | Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $67.58 | 2025 | Xdemvy |
| Optovue, INC. | $65.51 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $51.79 | 2021 | |
| Allergan, INC. | $46.63 | 2020-2021 | |
| Dompe US, INC. | $32.08 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $24.87 | 2021 | |
| Sun Pharmaceutical Industries INC. | $23.97 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $18.85 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.66 | 2020 | |
| Oyster Point Pharma, INC. | $14.71 | 2022 | |
| Thea Pharma INC. | $14.09 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Hopen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.